skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Medical Virology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection

Arase, Yasuji ; Ikeda, Kenji ; Suzuki, Fumitaka ; Suzuki, Yoshiyuki ; Kobayashi, Masahiro ; Akuta, Norio ; Hosaka, Tetsuya ; Sezaki, Hitomi ; Yatsuji, Hiromi ; Kawamura, Yusuke ; Kobayashi, Mariko ; Kumada, Hiromitsu

Journal of medical virology, 2007-10, Vol.79 (10), p.1485-1490 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
Clinical features and treatment of COVID‐19 patients in northeast Chongqing
Clinical features and treatment of COVID‐19 patients in northeast Chongqing
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical features and treatment of COVID‐19 patients in northeast Chongqing

Wan, Suxin ; Xiang, Yi ; Fang, Wei ; Zheng, Yu ; Li, Boqun ; Hu, Yanjun ; Lang, Chunhui ; Huang, Daoqiu ; Sun, Qiuyan ; Xiong, Yan ; Huang, Xia ; Lv, Jinglong ; Luo, Yaling ; Shen, Li ; Yang, Haoran ; Huang, Gu ; Yang, Ruishan

Journal of medical virology, 2020-07, Vol.92 (7), p.797-806 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Hepatic IFNL4 expression is associated with non‐response to interferon‐based therapy through the regulation of basal interferon‐stimulated gene expression in chronic hepatitis C patients
Hepatic IFNL4 expression is associated with non‐response to interferon‐based therapy through the regulation of basal interferon‐stimulated gene expression in chronic hepatitis C patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hepatic IFNL4 expression is associated with non‐response to interferon‐based therapy through the regulation of basal interferon‐stimulated gene expression in chronic hepatitis C patients

Murakawa, Miyako ; Asahina, Yasuhiro ; Kawai‐Kitahata, Fukiko ; Nakagawa, Mina ; Nitta, Sayuri ; Otani, Satoshi ; Nagata, Hiroko ; Kaneko, Shun ; Asano, Yu ; Tsunoda, Tomoyuki ; Miyoshi, Masato ; Itsui, Yasuhiro ; Azuma, Seishin ; Kakinuma, Sei ; Tanaka, Yasuhito ; Iijima, Sayuki ; Tsuchiya, Kaoru ; Izumi, Namiki ; Tohda, Shuji ; Watanabe, Mamoru

Journal of medical virology, 2017-07, Vol.89 (7), p.1241-1247 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Detectable SARS‐CoV‐2 viral RNA in feces of three children during recovery period of COVID‐19 pneumonia
Detectable SARS‐CoV‐2 viral RNA in feces of three children during recovery period of COVID‐19 pneumonia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Detectable SARS‐CoV‐2 viral RNA in feces of three children during recovery period of COVID‐19 pneumonia

Zhang, Tongqiang ; Cui, Xiaojian ; Zhao, Xue ; Wang, Jinhu ; Zheng, Jiafeng ; Zheng, Guifen ; Guo, Wei ; Cai, Chunquan ; He, Sijia ; Xu, Yongsheng

Journal of medical virology, 2020-07, Vol.92 (7), p.909-914 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
5
Clinical characteristics of 54 medical staff with COVID‐19: A retrospective study in a single center in Wuhan, China
Clinical characteristics of 54 medical staff with COVID‐19: A retrospective study in a single center in Wuhan, China
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical characteristics of 54 medical staff with COVID‐19: A retrospective study in a single center in Wuhan, China

Chu, Jiaojiao ; Yang, Nan ; Wei, Yanqiu ; Yue, Huihui ; Zhang, Fengqin ; Zhao, Jianping ; He, Li ; Sheng, Gaohong ; Chen, Peng ; Li, Gang ; Wu, Sisi ; Zhang, Bo ; Zhang, Shu ; Wang, Congyi ; Miao, Xiaoping ; Li, Juan ; Liu, Wenhua ; Zhang, Huilan

Journal of medical virology, 2020-07, Vol.92 (7), p.807-813 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID‐19: A retrospective study in two designated hospitals in Anhui, China
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID‐19: A retrospective study in two designated hospitals in Anhui, China
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID‐19: A retrospective study in two designated hospitals in Anhui, China

Zuo, Yan ; Liu, Yunlei ; Zhong, Qi ; Zhang, Ke ; Xu, Yuanhong ; Wang, Zhongxin

Journal of medical virology, 2020-11, Vol.92 (11), p.2666-2674 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
7
Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma
Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma

Takeyasu, Makiko ; Akuta, Norio ; Suzuki, Fumitaka ; Seko, Yuya ; Kawamura, Yusuke ; Sezaki, Hitomi ; Suzuki, Yoshiyuki ; Hosaka, Tetsuya ; Kobayashi, Masahiro ; Kobayashi, Mariko ; Arase, Yasuji ; Ikeda, Kenji ; Kumada, Hiromitsu

Journal of medical virology, 2012-08, Vol.84 (8), p.1199-1207 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
8
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy)
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy)

Halfon, Philippe ; Pérusat, Sophie ; Bourlière, Marc ; Bronowicki, Jean-Pierre ; Trimoulet, Pascale ; Benhamou, Yves ; Leroy, Vincent ; Marcellin, Patrick ; Foucher, Juliette ; Penaranda, Guillaume ; Chêne, Geneviève ; Couzigou, Patrice

Journal of medical virology, 2010-12, Vol.82 (12), p.2027-2031 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
9
Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg‐positive and HBeAg‐negative chronic hepatitis B
Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg‐positive and HBeAg‐negative chronic hepatitis B
Material Type:
Artigo 		Adicionar ao Meu Espaço

Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg‐positive and HBeAg‐negative chronic hepatitis B

Chuaypen, Natthaya ; Sriprapun, Methee ; Praianantathavorn, Kesmanee ; Payungporn, Sunchai ; Wisedopas, Naruemon ; Poovorawan, Yong ; Tangkijvanich, Pisit

Journal of medical virology, 2017-01, Vol.89 (1), p.130-138 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
CXCL13 variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients
CXCL13 variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

CXCL13 variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients

Luo, Mengqi ; Zhang, Lingyan ; Yang, Chou ; Zhou, Bin ; Hou, Jinlin ; Jiang, De‐Ke

Journal of medical virology, 2023-07, Vol.95 (7), p.e28963-n/a [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.